Coxsackievirus B4 strain E2


EVAg

Produced by
: IP
Shipping From
: Paris - FR

Product Description

Ref-SKU:
014V-03618
CV-B4 isolated in 1958, USA
Product Risk Group: 
Virus name: 

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
1 vial

In stock

1 000,00 €
(Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

GMO: 
No
Biosafety restrictions: 
This virus was isolated in the USA when wild poliovirus strains were still circulating. Therefore, it is considered as a WPV/VDPV potentially infected material and must be handled in compliance with the WHO GUIDANCE FOR NON-POLIOVIRUS FACILITIES TO MINIMIZE RISK OF SAMPLE COLLECTIONS POTENTIALLY INFECTIOUS FOR POLIOVIRUSES available at http://polioeradication.org/polio-today/preparing-for-a-polio-free-world/containment/containment-resources/.
Virus host type: 
Viral titer: 
10^7.9
Production cell line: 
Genbank reference: 
Virus Cultivability: 
Shipping conditions: 
IATA Classification: 

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Wednesday, 1 January, 1958
Country of collection: 
Suspected epidemiological origin : 

Comments (2)

  • Ping Jiang's picture

    Hi,

    I am Ping, a Principal Scientist at Moderna. would like to purchase this Coxsackievirus B4 strain E2. Would you please prepare a quote and email to me. Thanks a lot for your help.

    Best regards,

    Ping

    Feb 22, 2024
  • Ping Jiang's picture

    Hi,

    I am Ping, a Principal scientist at Moderna. I would like to purchase the Coxsackievirus B4 strain E2. Would you please prepare a quote for us and email to me: ping.jiang@modernatx.com.

    Thanks in advance for your help.

    Best regards,

    Ping

    Feb 22, 2024